These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 590850)

  • 41. Neutrophil adherence during hemoperfusion in fulminant hepatic failure.
    Altin M; Hughes RD; Williams R
    Int J Artif Organs; 1982 Sep; 5(5):315-7. PubMed ID: 7174138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trials and tribulations with artificial liver support.
    Williams R
    Gut; 1978 Jun; 19(6):578-83. PubMed ID: 355070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe coagulopathy complicating charcoal hemoperfusion in children with Reye syndrome.
    Engle WD; Jacobs JF; Swartz RD; Duff TE; Kelsch RC; Lane GA; Baublis JV
    J Pediatr; 1978 Dec; 93(6):972-4. PubMed ID: 722443
    [No Abstract]   [Full Text] [Related]  

  • 44. Hemostatic changes induced in vitro by hemoperfusion over activated charcoal.
    Winchester JF; MacKay JM; Forbes CD; Courtney JM; Gilchrist T; Prentice CR
    Artif Organs; 1978 Aug; 2(3):293-300. PubMed ID: 708293
    [No Abstract]   [Full Text] [Related]  

  • 45. Studies on plasma cytotoxicity and liver regeneration in fulminant hepatic failure.
    Williams R; Hughes RD; Cochrane AM; Ellis WR; Murray-Lyon IM
    Ciba Found Symp; 1977; (55):299-305. PubMed ID: 248004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of hemoperfusion with coated and uncoated charcoal on human blood in vitro.
    Ott NT; Kohnle W; Scheck R; Konstantin P; Franz HE
    J Dial; 1979; 3(4):291-308. PubMed ID: 263952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of prostacyclin in extracorporeal circulation.
    Ede RJ; Hughes RD; Williams R
    Int J Artif Organs; 1985 Nov; 8(6):297-300. PubMed ID: 3908327
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of prostaglandin E1 and adenosine on adverse platelet reactions during charcoal haemoperfusion.
    Langley PG; Hughes RD; Ton HY; Silk DB; Williams R
    Thromb Res; 1978 Sep; 13(3):351-60. PubMed ID: 741432
    [No Abstract]   [Full Text] [Related]  

  • 49. The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes.
    Hughes RD; Cochrane AM; Thomson AD; Murray-Lyon IM; Williams R
    Br J Exp Pathol; 1976 Jun; 57(3):348-53. PubMed ID: 986149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biocompatibility of haemoperfusion.
    Rommes JH; Sangster B; Berrens L; Borst C; van Heijst AN
    Arch Toxicol; 1986 Feb; 58(3):187-95. PubMed ID: 3964083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haemodialysis with charcoal haemoperfusion.
    Winchester JF; Apiliga MT; Mackay JM; Kennedy AC
    Proc Eur Dial Transplant Assoc; 1976; 12():526-33. PubMed ID: 935131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Plasmaperfusion through activated charcoal and amberlite XAD-7 in dogs with liver failure induced by yellow phosphorus (author's transl)].
    Horak W; Polterauer P; Renner F; Silberbauer K; Rauhs R; Mühlbacher F; Funovics J
    Z Gastroenterol; 1979 Feb; 17(2):90-8. PubMed ID: 425590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis?
    Higgins RM; Hearing S; Goldsmith DJ; Keevil B; Venning MC; Ackrill P
    Postgrad Med J; 1995 Apr; 71(834):224-6. PubMed ID: 7784283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
    Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
    Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
    [No Abstract]   [Full Text] [Related]  

  • 55. [The sorption effectiveness of Czech-manufactured hemoperfusion sorbents for amatoxins].
    Monhart V; Balíková M; Tlust'áková M
    Cas Lek Cesk; 1994 Mar; 133(6):181-3. PubMed ID: 8156574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Artificial liver support in fulminant hepatic failure.
    Williams R
    Bull N Y Acad Med; 1975 Apr; 51(4):508-18. PubMed ID: 1054614
    [No Abstract]   [Full Text] [Related]  

  • 57. Platelet function in chronic liver disease: relationship to disease severity.
    Rubin MH; Weston MJ; Langley PG; White Y; Williams R
    Dig Dis Sci; 1979 Mar; 24(3):197-202. PubMed ID: 456208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists.
    Chang TM
    Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coated charcoal haemoperfusion.
    Chang TM
    Life Support Syst; 1984; 2(2):99-106. PubMed ID: 6384672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coagulopathy of fulminant hepatic failure.
    O'Grady JG; Langley PG; Isola LM; Aledort LM; Williams R
    Semin Liver Dis; 1986 May; 6(2):159-63. PubMed ID: 3529409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.